Year: 2016

But the idea that doctors should necessarily put patients on diets is harmful, as is the accompanying … As obesity has become a health concern globally, weight loss information has proliferated … First, fat, in general, is not unhealthy.
Go to Source

One of China’s top coal-producing provinces has vowed to slash its level of fine particle pollution by one-fifth by 2020, the official Xinhua news agency reported on Saturday, citing the provincial government. China has adopted various measures from policing barbeques to halting industrial production in efforts to ease the yearly winter haze that hit the country earlier this month leaving cities veiled in foul-smelling smog. China’s northern Shanxi province aims to increase the proportion of days per year with good air quality to 75.4 percent, the agency said.
Go to Source

(Reuters) – OPKO Health Inc said its experimental drug for growth hormone deficiency (GHD) in adults failed to provide a statistically significant benefit over a placebo in a late-stage study, sending its shares down 14 percent in early trading. GHD is a rare disorder characterized by the inadequate secretion of the growth hormone from the pituitary gland, an organ responsible for the production of multiple hormones. Miami-based OPKO, which is developing the drug, hGH-CTP, with Pfizer Inc, said on Friday it had identified one or more outliers that may have affected the trial, in which patients were given the drug once a week.
Go to Source

In your efforts to get in shape again, not only is your diet extremely important, but how you eat those foods and what you eat those foods with, is also …
Go to Source

Eating after 6pm does not cause weight gain. Your metabolism continues to burn energy throughout the evening and also throughout the night.
Go to Source

Cempra Inc said on Thursday the U.S. Food and Drug Administration had rejected its antibiotic for community-acquired bacterial pneumonia (CABP), citing inadequate data on the drug’s impact on the liver and manufacturing issues. The FDA did not ask for further data on solithromycin’s effectiveness in treating CABP, Cempra said. An independent FDA panel narrowly backed the drug, solithromycin, in November, although a preliminary staff review by FDA scientists highlighted a potentially concerning rise in liver enzymes associated with its use.
Go to Source